ストックスクリーナーアプリを入手
7.12
2.45%
0.17
前日終値:
$6.95
開ける：
$6.97
24時間の取引高:
176.11K
Relative Volume:
0.83
時価総額：
$357.91M
収益：
-
当期純損益:
$-76.41M
株価収益率:
-3.7083
EPS:
-1.92
ネットキャッシュフロー:
$-64.56M
1週間 パフォーマンス:
+5.17%
1か月 パフォーマンス:
+15.21%
6か月 パフォーマンス:
-8.37%
1年 パフォーマンス:
-22.78%
1日の値動き範囲:
$6.91
$7.151
1週間の範囲:
$6.37
$7.151
52週間の値動き範囲:
$4.345
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
AURA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
7.12 | 419.77M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-28 | 再開されました | H.C. Wainwright | Buy |
| 2024-07-25 | 開始されました | H.C. Wainwright | Buy |
| 2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
| 2023-04-17 | 再開されました | BTIG Research | Buy |
| 2022-07-19 | 開始されました | JMP Securities | Mkt Outperform |
Aura Biosciences Inc (AURA) 最新ニュース
Clearside Biomedical Explores Strategic Options with FDA-Approved Eye Drug Platform | CLSD Stock News - Stock Titan
Why Guaranty Bancshares Inc. stock attracts strong analyst attentionConsistent Growth Alert - Newser
What makes Inventiva S.A. Depositary Receipt stock price move sharplyMarket Beating Strategy - Newser
How AVMU stock performs during market volatilityExpert Trading Flow - Newser
What makes Natera Inc. stock price move sharplyShort Squeeze Radar - Newser
What makes CAPS stock price move sharplyFree Best Performing Stock Alerts - Newser
Why Aura Biosciences Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
What makes Mistras Group Inc. stock price move sharplyFree Signals Group - Newser
What makes Aura Biosciences Inc. stock price move sharplyFree Access to Community - Newser
Why Hovnanian Enterprises Inc. Preferred Security stock attracts strong analyst attentionBest Stocks for Capital Safety - Newser
Why SOHON stock attracts strong analyst attentionProven Win Setups - Newser
How Aura Biosciences Inc. stock performs during market volatilityRisk Limited High Gain Trades - Newser
What makes XPRO stock price move sharplyBreakout Setup Scanner - Newser
What makes BILI stock price move sharplyShort Term Profit Focus - Newser
Certain Warrants of Aura Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 15-JUL-2025. - MarketScreener
Certain Common Stock. of Aura Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 15-JUL-2025. - MarketScreener
Long Term Trading Analysis for (AURA) - news.stocktradersdaily.com
Solid Biosciences to begin testing SGT-501 in U.S. and Canada (SLDB) - Seeking Alpha
Aura Minerals' Era Dorada: A High-Impact, Dividend-Friendly Gold Asset for 2025 and Beyond - AInvest
Aura Biosciences, Inc.(NasdaqGM: AURA) added to Russell Small Cap Comp Growth Index - MarketScreener
Aura Biosciences, Inc. (NASDAQ:AURA) Receives $22.00 Consensus PT from Analysts - Defense World
GAMMA Investing LLC Has $57,000 Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting - GlobeNewswire
Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail
Harbor Capital Advisors Inc. Takes Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
PTC Brings Cloud-Native Model-Based Definition to Onshape - The Globe and Mail
Company News for Jun 13, 2025 - The Globe and Mail
Bank of America Corp DE Increases Stock Holdings in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
GameStop Turns a Profit, But Core Business Keeps Shrinking - The Globe and Mail
Two Sigma Investments LP Reduces Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Kantar appoints Jeff Greenspoon as CEO, Americas - The Globe and Mail
Kernaghan buying at Western Forest Products (WEF) - The Globe and Mail
BNP Paribas Financial Markets Invests $50,000 in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
15,427 Shares in Aura Biosciences, Inc. (NASDAQ:AURA) Acquired by ProShare Advisors LLC - Defense World
Ameriprise Financial Inc. Has $704,000 Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Option Volatility And Earnings Report For June 26 - The Globe and Mail
Learn to Evaluate (AURA) using the Charts - news.stocktradersdaily.com
Brokers Set Expectations for AURA Q2 Earnings - Defense World
Deutsche Bank AG Buys 15,951 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Equities Analysts Offer Predictions for AURA FY2028 Earnings - Defense World
Aura Biosciences (NASDAQ:AURA) Raised to Buy at HC Wainwright - Defense World
H.C. Wainwright sets $22 target for Aura Biosciences stock By Investing.com - Investing.com Canada
Aura Biosciences (AURA) Receives 'Buy' Rating from HC Wainwright & Co. | AURA Stock News - GuruFocus
H.C. Wainwright sets $22 target for Aura Biosciences stock - Investing.com
Aura Biosciences assumed with a Buy at H.C. Wainwright - TipRanks
AURA: Analyst Initiates Buy Rating with $22 Price Target | AURA Stock News - GuruFocus
Innovative Precision Oncology and Promising Clinical Results Justify Buy Rating for Aura Biosciences Inc - TipRanks
Aura Biosciences (NASDAQ:AURA) Earns Market Outperform Rating from JMP Securities - Defense World
Northern Trust Corp Has $3.18 Million Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura Biosciences Inc (AURA) 財務データ
収益
当期純利益
現金流量
EPS
0.64%
0.37%
大文字化:
|
ボリューム (24 時間):